Triptolide derivatives for modulation of apoptosis and immunosuppression
CA 2485794 C · Owner: Musser, John H. · Inventors: Lennox, Edwin S.; Musser, John H.; Dai, Dongcheng
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Variously substituted carbonate and carbamate derivatives of triptolide compounds have good aqueous solubility and convert to biologically active compounds in vivo, at a rate which can be modulated by varying the substitution on the prodrug. The prodrugs are useful as immunosuppressive anti-inflammatory and anticancer agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 29, 2003 and granted October 16, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 29, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 29, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.